Workboat Indexes
All News about Genmab A/S ADR
![](https://mms.businesswire.com/media/20230719052574/en/1845268/5/Genmab_Logo_Color_RGB.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600.jpg)
![](https://g.foolcdn.com/editorial/images/738087/a-doctor-examines-a-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/28/gmab.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Where Genmab Stands With Analysts
June 26, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Genmab
June 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Genmab Q1 Earnings
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Price Over Earnings Overview: Genmab
April 27, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230627408516/en/1830065/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20230622467458/en/1825131/5/Genmab_Logo_Color_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_9182.png?width=1200&height=800&fit=crop)
Analyst Ratings for Genmab
April 20, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
P/E Ratio Insights for Genmab
April 11, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
This Foreboding Sign Looms Over Genmab's Chart
March 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 4 Analyst Ratings Have To Say About Genmab
March 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Genmab
February 21, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230609005027/en/1814347/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20230525005851/en/1803969/5/Genmab_Logo_Color_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/19/thumbs_up.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230518005495/en/1797676/5/Genmab_Logo_Color_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/gmab.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://mms.businesswire.com/media/20230416005028/en/1764657/5/Genmab_logo.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.